Clinical Trials Browser

Interventional × Cabergoline × Clear all

NCT07463235 2026-03-13

SPARAGMOS

Phase 3 Recruiting

Hyperprolactinemia, Prolactinoma

NCT07045935 2025-09-23

ProBOLIC

Phase 4 Recruiting

Prolactin Deficiency, Isolated, Hyperprolactinemia, Prolactinoma

NCT07168837 2025-09-11

Letrozole and Cabergoline Versus Letrozole Alone in Ovulation Induction

Phase NA Completed

Polycystic Ovary Syndrome

NCT07034859 2025-06-24

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

Phase 4 Enrolling by invitation

Pituitary Neoplasms

NCT02288962 2025-06-08

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

Phase 3 Active not recruiting

Adenoma, Pituitary Neoplasms

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Phase 4 Completed

337 enrolled 8 charts

DermatologicEndocrineGenitourinaryNET

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT05981742 2023-08-08

Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS

Phase 2 Completed

Polycystic Ovary Syndrome

NCT01915303 2020-09-18

Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease

Phase 2 Terminated

68 enrolled 25 charts

Adrenocortical Hyperfunction, Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT03457389 2020-03-18

Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

Phase NA Unknown

Pituitary Neoplasms, Recurrence, Prolactinoma

NCT01730729 2019-09-17

Cabergoline in Metastatic Breast Cancer

Phase EARLY_PHASE1 Completed

20 enrolled 11 charts

Breast Neoplasms

NCT03271918 2017-09-07

Cabergoline in Nonfunctioning Pituitary Adenomas

Phase 3 Completed

Pituitary Neoplasms

NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Phase 4 Completed

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

NCT01620138 2016-08-22

Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas

Phase 2/3 Completed

21 enrolled 4 charts

Prolactinoma

NCT01569256 2012-04-04

Ovarian Hyperstimulation Syndrome and Cabergoline

Phase NA Completed

Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome

NCT01143584 2010-06-14

Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.

Phase NA Unknown

Prolactinoma

NCT00889525 2009-04-29

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

Phase 3 Completed

Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma